These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 20332717)

  • 21. [Nasal budesonide plus zafirlukast vs nasal budesonide plus loratadine-pseudoephedrine for controlling the symptoms of rhinitis and asthma].
    Benitez HH; Arvizu VM; Gutiérrez DJ; Fogelbach GA; Castellanos Olivares A; Vázquez Nava F; Velázquez HC; González Pérez Mdel C; Mora Nieto A; Rodríguez EC
    Rev Alerg Mex; 2005; 52(2):90-5. PubMed ID: 16158782
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Leukotriene-receptor antagonists.
    Lipworth BJ
    Lancet; 1999 Jan; 353(9146):57-62. PubMed ID: 10023966
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Leukotriene antagonists--do they have a value?].
    Stey C
    Praxis (Bern 1994); 2000 Mar; 89(14):586-90. PubMed ID: 10815466
    [TBL] [Abstract][Full Text] [Related]  

  • 24. New treatments for asthma: the role of leukotriene modifier agents.
    Valacer DJ
    J Natl Med Assoc; 1999 Aug; 91(8 Suppl):26S-39S. PubMed ID: 12653390
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Should antileukotriene therapies be used instead of inhaled corticosteroids in asthma? Yes.
    Drazen JM; Israel E
    Am J Respir Crit Care Med; 1998 Dec; 158(6):1697-8. PubMed ID: 9847254
    [No Abstract]   [Full Text] [Related]  

  • 26. Role of antileukotriene agents in asthma therapy.
    Gawchik SM; Saccar CL
    J Am Osteopath Assoc; 2000 Jan; 100(1):32, 37-43. PubMed ID: 10693315
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Asthma treatment: antileukotriene drugs.
    O'Byrne PM
    Can Respir J; 1998; 5 Suppl A():64A-70A. PubMed ID: 9753521
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Leukotriene antagonists].
    Mallet JP
    Allerg Immunol (Paris); 1999 Apr; 31(4):113-6. PubMed ID: 10370724
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [The use of leukotriene receptor antagonists and 5-lipoxygenase inhibitors in bronchial asthma treatment].
    Kuziemski K; Mincewicz G; Sopel R; Słomiński JM
    Pol Merkur Lekarski; 1998 Dec; 5(30):317-20. PubMed ID: 10101512
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [The therapeutic potentials of antileukotriene preparations in bronchial asthma patients].
    Fedoseev GB; Emel'ianov AV; Krasnoshchekova OI
    Ter Arkh; 1998; 70(8):81-4. PubMed ID: 9770758
    [No Abstract]   [Full Text] [Related]  

  • 31. Montelukast in paediatric asthma: where we are now and what still needs to be done?
    Bush A
    Paediatr Respir Rev; 2015 Mar; 16(2):97-100. PubMed ID: 25499571
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The expanding role of leukotriene receptor antagonists in chronic asthma.
    Currie GP; McLaughlin K
    Ann Allergy Asthma Immunol; 2006 Dec; 97(6):731-41, quiz 741-2, 793. PubMed ID: 17201231
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Leukotriene modifiers in the treatment of asthma in children.
    del Giudice MM; Pezzulo A; Capristo C; Alterio E; Caggiano S; de Benedictis D; Capristo AF
    Ther Adv Respir Dis; 2009 Oct; 3(5):245-51. PubMed ID: 19822630
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Therapeutic modulation of allergic airways disease with leukotriene receptor antagonists.
    Currie GP; Srivastava P; Dempsey OJ; Lee DK
    QJM; 2005 Mar; 98(3):171-82. PubMed ID: 15728398
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparative evaluation of the leukotriene receptor antagonist pranlukast versus the steroid inhalant fluticasone in the therapy of aged patients with mild bronchial asthma.
    Horiguchi T; Tachikawa S; Kondo R; Miyazaki J; Shiga M; Hirose M; Kobayashi K; Hayashi N; Ohira D; Nasu T; Otake Y; Hata H
    Arzneimittelforschung; 2007; 57(2):87-91. PubMed ID: 17396618
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Leukotrienes in respiratory disease.
    McMillan RM
    Paediatr Respir Rev; 2001 Sep; 2(3):238-44. PubMed ID: 12052325
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Efficacy of antileukotriene agents in asthma management.
    Nathan RA; Kemp JP;
    Ann Allergy Asthma Immunol; 2001 Jun; 86(6 Suppl 1):9-17. PubMed ID: 11426917
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Efficacy and safety of montelukast in adults with asthma and allergic rhinitis.
    Virchow JC; Bachert C
    Respir Med; 2006 Nov; 100(11):1952-9. PubMed ID: 16626955
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antitussive effect of the leukotriene receptor antagonist zafirlukast in subjects with cough-variant asthma.
    Dicpinigaitis PV; Dobkin JB; Reichel J
    J Asthma; 2002 Jun; 39(4):291-7. PubMed ID: 12095178
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Urinary leukotriene LTE4 levels in non-responders to antileukotriene therapy.
    Lee DK
    Thorax; 2004 Aug; 59(8):727; author reply 727. PubMed ID: 15282399
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.